Mainz Biomed N.V [MYNZ] stock is trading at $0.23, down -5.66%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MYNZ shares have gain 4.74% over the last week, with a monthly amount drifted -25.70%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Mainz Biomed N.V [NASDAQ: MYNZ] stock has seen the most recent analyst activity on November 21, 2023, when Cantor Fitzgerald downgraded its rating to a Neutral. Previously, H.C. Wainwright started tracking the stock with Buy rating on June 21, 2022, and set its price target to $25.
Mainz Biomed N.V [MYNZ] stock has fluctuated between $0.19 and $1.79 over the past year. Mainz Biomed N.V [NASDAQ: MYNZ] shares were valued at $0.23 at the most recent close of the market.
Analyzing the MYNZ fundamentals
Gross Profit Margin for this corporation currently stands at 0.57% with Operating Profit Margin at -31.23%, Pretax Profit Margin comes in at -30.58%, and Net Profit Margin reading is -30.58%. To continue investigating profitability, this company’s Return on Assets is posted at -1.28, Equity is -4.99 and Total Capital is -3.27. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.84.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2132 points at the first support level, and at 0.2013 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2379, and for the 2nd resistance point, it is at 0.2507.
Ratios To Look Out For
For context, Mainz Biomed N.V’s Current Ratio is 0.97. Also, the Quick Ratio is 0.91, while the Cash Ratio stands at 0.77. Considering the valuation of this stock, the price to sales ratio is 5.22, the price to book ratio is 1.47.
